Cargando…

Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties

A number of 2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl) benzamides (1a–h) were synthesized via reaction of 2-((4-ethylphenoxy)methyl)benzoyl isothiocyanate (2) as a key intermediate with several substituted primary aromatic amines. The new compounds were characterized by proton nu...

Descripción completa

Detalles Bibliográficos
Autores principales: Limban, Carmen, Missir, Alexandru Vasile, Fahelelbom, Khairi Mustafa Salem, Al-Tabakha, Moawia Mohammad, Caproiu, Miron Teodor, Sadek, Bassem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770517/
https://www.ncbi.nlm.nih.gov/pubmed/24039398
http://dx.doi.org/10.2147/DDDT.S46691
_version_ 1782284095949111296
author Limban, Carmen
Missir, Alexandru Vasile
Fahelelbom, Khairi Mustafa Salem
Al-Tabakha, Moawia Mohammad
Caproiu, Miron Teodor
Sadek, Bassem
author_facet Limban, Carmen
Missir, Alexandru Vasile
Fahelelbom, Khairi Mustafa Salem
Al-Tabakha, Moawia Mohammad
Caproiu, Miron Teodor
Sadek, Bassem
author_sort Limban, Carmen
collection PubMed
description A number of 2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl) benzamides (1a–h) were synthesized via reaction of 2-((4-ethylphenoxy)methyl)benzoyl isothiocyanate (2) as a key intermediate with several substituted primary aromatic amines. The new compounds were characterized by proton nuclear magnetic resonance ((1)H-NMR), carbon-13 nuclear magnetic resonance ((13)C-NMR), infrared spectrometry (IR), mass spectrometry (MS), and elemental analysis. The anti-inflammatory activity of 1a–h was investigated by acute carrageenan-induced paw edema in mice using the reference drug indomethacin. The results obtained indicated that, of the derivatives developed, 1a and 1d–h exhibited significantly higher anti-inflammatory activity (26.81%–61.45%) when compared with the reference drug indomethacin (22.43%) (P = 0.0490 for 1a, 0.0015 for 1d, 0.0330 for 1f, and P < 0.001 for 1e and 1h). Moreover, the ulcer incidence of 20% for 1e and 1h was clearly lower when compared with the indomethacin group (in which the ulcer incidence was 80%). Of particular note, the ulcer index of 0.2 for 1e was significantly less than that in the indomethacin group (0.6, P = 0.014). Additionally, prostaglandin E(2) (PGE(2)) inhibitory properties were found to be high with 1e (68.32 pg/mL), significantly different from those of the placebo group (530.13 pg/mL, P < 0.001), and equipotent to the effect observed in the indomethacin-pretreated group (96.13 pg/mL, P > 0.05). Moreover, the PGE(2) level of 54.15 pg/mL with 1h was also significantly different from that of the placebo group (P < 0.001) and of the indomethacin group (P < 0.05). The significant inhibition of PGE(2) observed with 1e (68.32 pg/mL) and 1h (54.15 pg/mL) agree with their observed ulcer incidences. Our overall findings for N-phenylcarbamothioylbenzamides 1a–h clearly suggest that the compounds exhibit an anti-inflammatory effect, potently inhibit PGE(2) synthesis, and markedly demonstrate low ulcer incidence.
format Online
Article
Text
id pubmed-3770517
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-37705172013-09-13 Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties Limban, Carmen Missir, Alexandru Vasile Fahelelbom, Khairi Mustafa Salem Al-Tabakha, Moawia Mohammad Caproiu, Miron Teodor Sadek, Bassem Drug Des Devel Ther Original Research A number of 2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl) benzamides (1a–h) were synthesized via reaction of 2-((4-ethylphenoxy)methyl)benzoyl isothiocyanate (2) as a key intermediate with several substituted primary aromatic amines. The new compounds were characterized by proton nuclear magnetic resonance ((1)H-NMR), carbon-13 nuclear magnetic resonance ((13)C-NMR), infrared spectrometry (IR), mass spectrometry (MS), and elemental analysis. The anti-inflammatory activity of 1a–h was investigated by acute carrageenan-induced paw edema in mice using the reference drug indomethacin. The results obtained indicated that, of the derivatives developed, 1a and 1d–h exhibited significantly higher anti-inflammatory activity (26.81%–61.45%) when compared with the reference drug indomethacin (22.43%) (P = 0.0490 for 1a, 0.0015 for 1d, 0.0330 for 1f, and P < 0.001 for 1e and 1h). Moreover, the ulcer incidence of 20% for 1e and 1h was clearly lower when compared with the indomethacin group (in which the ulcer incidence was 80%). Of particular note, the ulcer index of 0.2 for 1e was significantly less than that in the indomethacin group (0.6, P = 0.014). Additionally, prostaglandin E(2) (PGE(2)) inhibitory properties were found to be high with 1e (68.32 pg/mL), significantly different from those of the placebo group (530.13 pg/mL, P < 0.001), and equipotent to the effect observed in the indomethacin-pretreated group (96.13 pg/mL, P > 0.05). Moreover, the PGE(2) level of 54.15 pg/mL with 1h was also significantly different from that of the placebo group (P < 0.001) and of the indomethacin group (P < 0.05). The significant inhibition of PGE(2) observed with 1e (68.32 pg/mL) and 1h (54.15 pg/mL) agree with their observed ulcer incidences. Our overall findings for N-phenylcarbamothioylbenzamides 1a–h clearly suggest that the compounds exhibit an anti-inflammatory effect, potently inhibit PGE(2) synthesis, and markedly demonstrate low ulcer incidence. Dove Medical Press 2013-08-28 /pmc/articles/PMC3770517/ /pubmed/24039398 http://dx.doi.org/10.2147/DDDT.S46691 Text en © 2013 Limban et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.
spellingShingle Original Research
Limban, Carmen
Missir, Alexandru Vasile
Fahelelbom, Khairi Mustafa Salem
Al-Tabakha, Moawia Mohammad
Caproiu, Miron Teodor
Sadek, Bassem
Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties
title Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties
title_full Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties
title_fullStr Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties
title_full_unstemmed Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties
title_short Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties
title_sort novel n-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin e(2) inhibitory properties
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770517/
https://www.ncbi.nlm.nih.gov/pubmed/24039398
http://dx.doi.org/10.2147/DDDT.S46691
work_keys_str_mv AT limbancarmen novelnphenylcarbamothioylbenzamideswithantiinflammatoryactivityandprostaglandine2inhibitoryproperties
AT missiralexandruvasile novelnphenylcarbamothioylbenzamideswithantiinflammatoryactivityandprostaglandine2inhibitoryproperties
AT fahelelbomkhairimustafasalem novelnphenylcarbamothioylbenzamideswithantiinflammatoryactivityandprostaglandine2inhibitoryproperties
AT altabakhamoawiamohammad novelnphenylcarbamothioylbenzamideswithantiinflammatoryactivityandprostaglandine2inhibitoryproperties
AT caproiumironteodor novelnphenylcarbamothioylbenzamideswithantiinflammatoryactivityandprostaglandine2inhibitoryproperties
AT sadekbassem novelnphenylcarbamothioylbenzamideswithantiinflammatoryactivityandprostaglandine2inhibitoryproperties